Latest Insider Transactions at Cvs Health Corp (CVS)
This section provides a real-time view of insider transactions for Cvs Health Corp (CVS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of CVS HEALTH Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of CVS HEALTH Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 27
2016
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
192
-0.72%
|
$18,624
$97.66 P/Share
|
|
Feb 27
2016
|
Robert O. Kraft EVP and President - Omnicare |
SELL
Payment of exercise price or tax liability
|
Direct |
422
-6.17%
|
$40,934
$97.66 P/Share
|
|
Feb 19
2016
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
463
-1.74%
|
$44,911
$97.59 P/Share
|
|
Feb 18
2016
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
346
-1.35%
|
$33,216
$96.89 P/Share
|
|
Feb 11
2016
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
23,355
-44.92%
|
$2,148,660
$92.86 P/Share
|
|
Feb 01
2016
|
Larry J Merlo Director |
SELL
Open market or private sale
|
Direct |
46,393
-22.3%
|
$4,453,728
$96.14 P/Share
|
|
Feb 01
2016
|
Larry J Merlo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
46,393
+18.24%
|
$1,299,004
$28.1 P/Share
|
|
Jan 11
2016
|
Larry J Merlo Director |
SELL
Open market or private sale
|
Direct |
46,393
-22.3%
|
$4,407,335
$95.0 P/Share
|
|
Jan 11
2016
|
Larry J Merlo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
46,393
+18.24%
|
$1,299,004
$28.1 P/Share
|
|
Jan 04
2016
|
Anne A. Finucane Director |
SELL
Open market or private sale
|
Indirect |
2,000
-11.96%
|
$190,000
$95.87 P/Share
|
|
Jan 02
2016
|
Helena Foulkes EVP & President-CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct |
748
-2.28%
|
$71,808
$96.46 P/Share
|
|
Nov 25
2015
|
Anne A. Finucane Director |
SELL
Bona fide gift
|
Indirect |
600
-3.46%
|
$55,800
$93.9 P/Share
|
|
Nov 12
2015
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Bona fide gift
|
Direct |
175
-0.34%
|
$16,275
$93.12 P/Share
|
|
Nov 04
2015
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
843
+16.38%
|
$83,457
$99.57 P/Share
|
|
Nov 04
2015
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,054
+27.26%
|
$104,346
$99.57 P/Share
|
|
Nov 04
2015
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,862
+4.13%
|
$283,338
$99.57 P/Share
|
|
Nov 04
2015
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,406
+50.0%
|
$139,194
$99.57 P/Share
|
|
Nov 04
2015
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,054
+50.0%
|
$104,346
$99.57 P/Share
|
|
Nov 04
2015
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,054
+5.15%
|
$104,346
$99.57 P/Share
|
|
Oct 27
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
23,603
-27.62%
|
$2,478,315
$105.0 P/Share
|
|
Oct 27
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
23,603
+21.64%
|
$1,274,562
$54.53 P/Share
|
|
Aug 31
2015
|
Robert O. Kraft EVP and President - Omnicare |
BUY
Grant, award, or other acquisition
|
Direct |
5,502
+50.0%
|
$561,204
$102.4 P/Share
|
|
Aug 31
2015
|
Robert O. Kraft EVP and President - Omnicare |
BUY
Grant, award, or other acquisition
|
Direct |
5,502
+50.0%
|
$561,204
$102.4 P/Share
|
|
Jul 20
2015
|
Eva C Boratto EVP & CFO |
SELL
Open market or private sale
|
Direct |
22,107
-47.64%
|
$2,431,770
$110.34 P/Share
|
|
Jul 20
2015
|
Eva C Boratto EVP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
22,107
+32.27%
|
$663,210
$30.16 P/Share
|
|
Jul 19
2015
|
Eva C Boratto EVP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,661
-21.51%
|
$732,710
$110.14 P/Share
|
|
Jul 15
2015
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Open market or private sale
|
Direct |
49,908
-28.13%
|
$5,489,880
$110.0 P/Share
|
|
Jul 15
2015
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
41,982
+21.96%
|
$2,183,064
$52.68 P/Share
|
|
Jun 01
2015
|
C David Brown Ii Director |
SELL
Open market or private sale
|
Direct |
10,000
-9.88%
|
$1,020,000
$102.57 P/Share
|
|
May 07
2015
|
Jean Pierre Millon Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,056
+50.0%
|
$104,544
$99.36 P/Share
|
|
May 07
2015
|
Tony L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,056
+5.44%
|
$104,544
$99.36 P/Share
|
|
May 07
2015
|
Anne A. Finucane Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,409
+50.0%
|
$139,491
$99.36 P/Share
|
|
May 07
2015
|
David W Dorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,868
+4.31%
|
$283,932
$99.36 P/Share
|
|
May 07
2015
|
Richard M Bracken Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,056
+37.51%
|
$104,544
$99.36 P/Share
|
|
May 07
2015
|
Nancy Ann Deparle Director |
BUY
Grant, award, or other acquisition
|
Direct |
845
+19.62%
|
$83,655
$99.36 P/Share
|
|
May 01
2015
|
C David Brown Ii Director |
SELL
Open market or private sale
|
Direct |
15,000
-12.9%
|
$1,500,000
$100.27 P/Share
|
|
Apr 10
2015
|
Andrew Sussman EVP, Clinical Services |
SELL
Open market or private sale
|
Direct |
17,638
-32.83%
|
$1,799,076
$102.38 P/Share
|
|
Apr 10
2015
|
Andrew Sussman EVP, Clinical Services |
BUY
Exercise of conversion of derivative security
|
Direct |
12,556
+23.67%
|
$615,244
$49.8 P/Share
|
|
Apr 02
2015
|
Lisa Bisaccia Former EVP & Chief HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,862
-6.05%
|
$189,924
$102.71 P/Share
|
|
Apr 02
2015
|
Andrew Sussman EVP, Clinical Services |
SELL
Payment of exercise price or tax liability
|
Direct |
1,596
-10.27%
|
$162,792
$102.71 P/Share
|
|
Apr 02
2015
|
Helena Foulkes EVP & President-CVS Pharmacy |
SELL
Payment of exercise price or tax liability
|
Direct |
2,394
-7.31%
|
$244,188
$102.71 P/Share
|
|
Apr 02
2015
|
Larry J Merlo Director |
SELL
Payment of exercise price or tax liability
|
Direct |
19,944
-10.99%
|
$2,034,288
$102.71 P/Share
|
|
Apr 02
2015
|
Jonathan C Roberts EVP & Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,654
-8.2%
|
$474,708
$102.71 P/Share
|
|
Apr 02
2015
|
David M Denton EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,648
-5.59%
|
$678,096
$102.71 P/Share
|
|
Apr 02
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
16,637
-21.2%
|
$1,696,974
$102.71 P/Share
|
|
Apr 02
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
16,637
+17.49%
|
$748,665
$45.07 P/Share
|
|
Apr 02
2015
|
Troyen A Brennan EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,989
-6.06%
|
$406,878
$102.71 P/Share
|
|
Apr 02
2015
|
J. David Joyner EVP&President-PharmacyServices |
SELL
Payment of exercise price or tax liability
|
Direct |
1,862
-3.15%
|
$189,924
$102.71 P/Share
|
|
Apr 01
2015
|
Stephen J Gold EVP & CIO |
BUY
Grant, award, or other acquisition
|
Direct |
5,867
+13.56%
|
$598,434
$102.26 P/Share
|
|
Apr 01
2015
|
Lisa Bisaccia Former EVP & Chief HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,889
+15.33%
|
$498,678
$102.26 P/Share
|